Home › Migraine › Virginia › Charlottesville
Migraine clinical trials in Charlottesville, VA
3 studies for Migraine are looking for participants at sites in and around Charlottesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
RecruitingPhase 3
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
RecruitingPhase 3
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
RecruitingPhase 3
- Pediatric Associates of Charlottesville, PLC /ID# 230628, Charlottesville
About Migraine
Migraines are pulsing or throbbing headaches in one area of the head. Learn about other symptoms, what triggers migraines, and how to treat them.
More about Migraine on MedlinePlus
Migraine trials in other cities
- Cincinnati, OH12 studies
- Omaha, NE9 studies
- Austin, TX9 studies
- Aurora, CO8 studies
- Miami, FL8 studies
- Stamford, CT8 studies
- Atlanta, GA8 studies
- Washington, DC8 studies
- Phoenix, AZ7 studies
- Philadelphia, PA7 studies
- Tampa, FL7 studies
- San Diego, CA7 studies
Other studies in Charlottesville
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia16 studies
- Prostate Cancer15 studies
- Endometrial Cancer15 studies
- Cancer (all types)14 studies
- Lung Cancer13 studies
- Metastatic Cancer12 studies
- Heart Failure11 studies
- Colorectal Cancer10 studies
- Pancreatic Cancer10 studies
- Ovarian Cancer9 studies
- Ischemic Stroke9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.